Legal & General Group
HURA

Legal & General Group’s TuHURA Biosciences HURA Stock Holding History

Legal & General Group’s Portfolio HURA Stock Details HURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-4,999
Closed -$8.95K – 3560
2026
Q1 		$8.95K Buy
4,999
+2,138
+75% +$2.62K ﹤0.01% 3206
2025
Q4 		$2.17K Hold
2,861
– – ﹤0.01% 3373
2025
Q3 		$7.1K Hold
2,861
– – ﹤0.01% 3338
2025
Q2 		$6.38K Buy
+2,861
New +$9.67K ﹤0.01% 3365

Other funds holding HURA

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Legal & General Group's HURA Position: Q2 2026 in Review

Legal & General Group sold out of TuHURA Biosciences (HURA) in Q2 2026, closing a stake of 4,999 shares — an estimated $8.95K sold.

Legal & General Group first reported a position in HURA in Q2 2025 and held it in 4 quarters. The position peaked at $8.95K in Q1 2026. 90 funds tracked by Wall St. Rank hold HURA as of Q2 2026.

  • Legal & General Group reported no remaining TuHURA Biosciences position as of Q2 2026 after selling out during the quarter.
  • Legal & General Group sold 4,999 TuHURA Biosciences shares in Q2 2026, an estimated $8.95K.
  • Legal & General Group first reported a position in TuHURA Biosciences in Q2 2025 and held it in 4 quarters.
  • Legal & General Group's TuHURA Biosciences position peaked at $8.95K in Q1 2026.
  • 90 funds tracked by Wall St. Rank held TuHURA Biosciences as of Q2 2026.

Based on Legal & General Group's 13F filing for Q2 2026, filed 14 Aug 2026.